Format

Send to

Choose Destination
J Neurooncol. 2017 May;133(1):221. doi: 10.1007/s11060-017-2485-x.

Erratum to: Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.

Author information

1
Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA. dcagney@lroc.harvard.edu.
2
Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
3
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
PMID:
28527005
DOI:
10.1007/s11060-017-2485-x

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center